Sanofi, GSK To Supply COVAX With 200 Million Doses Of COVID-19 Vaccine
Bhubaneswar, Oct. 29 -- New Delhi: Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines.
Sanofi and GSK intend to make available 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine, if approved by regulatory authorities and subject to contract, to the COVAX Facility.
Both Companies intend to contribute to COVAX's ambition to ensure successful COVID-19 vaccines reach those in need, whoever they are and wherever they live, once they obtain appropriate approvals.
"To address a global health crisis of this magnitude, it takes unique partnerships. T...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.